Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06791707
Active, not recruiting Observational

Evaluation of Periodontal Health, Salivary Cotinine and S100A8/A9 Levels in Children Exposed to Passive Smoking

NCT06791707 · tracked via the Priya Life Science Turkey tracker
Sponsor
Cumhuriyet University
Phase
Observational
Started
2025-02-24
Last updated
2025-11-25

Condition(s) studied

Secondhand Smoke ExposureChildrenInflamationCotinine Levels

Study summary

The periodontal health of children exposed to passive smoking will be evaluated by S100A8 and S100A9 levels.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Systemically and genetically healthy children Exclusion Criteria: * Any medications known to affect defense system and periodontium * The presence of orthodontic / intraoral appliance

Primary outcome measure(s)

  • Protein marker — Within 1 year
    S100A8/A9 (pg/mL)

Trial sites (1)

FacilityCityRegionStatus
Cumhuriyet University Sivas Turkey (Türkiye)

More Cumhuriyet University trials in Turkey

S-TAP vs RSB in Midline Abdominal Incision Laparotomy Active, not recruiting
The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery Recruiting
Comprasion of SPSIP and Rhomboid Intercostal Plan Blocks on VATS Recruiting
ARCS-Based Training to Improve Nursing Students' Communication, Motivation, and Self-Efficacy Recruiting
Analgesic Effect of M-TAPA and TAPB on Laparoscopic Cholesistectomy Recruiting

Other trials for the same condition

Walkway Used in Postoperative Mobilization Active, not recruiting
Phoenixin and Pain in Pediatric Burn Patients Starting soon
Effect of Vibration and ShotBlocker on Pain and Fear Levels During Intramuscular Injection in Children in the Emergency Department Recruiting
Effects of Cartoons and Mobile Games on Preoperative Anxiety and Fear in Children With Appendicitis: An RCT Recruiting
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06791707 on ClinicalTrials.gov ↗ ← All trials in Turkey